Intravenous (i.v.) peramivir is available within the U.S. through an emergency use investigational new drug process (EIND) for eligible patients with influenza requiring hospitalization.
Please contact a BioCryst Physician by calling 205-989-3262 for initial evaluation of a potential case. Following a successful evaluation, you will be provided with a password to access the required forms to complete the process available at the following link: EIND instructions and forms